GEA Simultaneous to VSG Reduces Post-operative GERD
Summary
NIH registered a clinical trial (NCT07537244) to evaluate whether adding gastroenteroanastomosis (GEA) to vertical sleeve gastrectomy (VSG) reduces post-operative gastroesophageal reflux disease (GERD) in obese patients. The randomized study will compare Group A (VSG with GEA) versus Group B (VSG without GEA) using symptom questionnaires during follow-up visits. All exams are part of standard surgical or GERD follow-up routines, with an estimated start date of April 17, 2026.
What changed
This ClinicalTrials.gov registration documents the addition of a new randomized clinical trial evaluating whether gastroenteroanastomosis performed simultaneously with vertical sleeve gastrectomy reduces the incidence of post-operative GERD in patients with obesity. The trial enrolls adult participants and uses standard symptom questionnaires during follow-up visits.
Healthcare providers and clinical investigators involved in bariatric surgery research should note this trial's design and enrollment criteria. The study's findings could inform future surgical protocols for managing reflux symptoms in sleeve gastrectomy patients. No compliance obligations or regulatory deadlines are associated with this trial registration.
Archived snapshot
Apr 18, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Impact of GEA Simultaneous to VSG on Post-operative GERD
N/A NCT07537244 Kind: NA Apr 17, 2026
Abstract
The goal of this clinical trial is to evaluate the effect of GEA on GERD in patients undergoing VSG. The main question it aims to answer is:
• Does adoption of GEA to VSG reduce the occurrence of GERD? Participants will complete a symptom questionnaire during follow-up visits. All exams are already part of the surgical or GERD follow-up routine.
Researchers will compare with GEA (Group A) and Without GEA (Group B) to see if adopting GEA during VSG reduces the occurrence of GERD.
Conditions: Obesity, Reflux, Gastroesophageal
Interventions: gastroenteroanastomosis simultaneous to vertical sleeve gastrectomy, vertical sleeve gastrectomy
Named provisions
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.